Clinical Trials Browser

Completed × beta-Thalassemia × Clear all

Breast Neoplasms, Heart Diseases, beta-Thalassemia, Cardiotoxicity

NCT02604433 2023-04-18

BELIEVE

Phase 3 Completed

336 enrolled 38 charts 1 FDA

beta-Thalassemia

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

Phase 2 Completed

20 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Clinical Trials

AQUA

BELIEVE

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant